Deutsche Bank Lowers PT On Merck & Co.

January 21, 2011 7:10 AM | 8 seconds read | Make a Comment

Deutsche Bank has lowered the price target on Merck & Co.

MRK

from $48 to $43 and maintains its Buy rating.

Posted In: Price Target Analyst Ratings Deutsche Bank Health Care Merck & Company Pharmaceuticals

Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.